Hyperlipidemia

Mar 28, 2020

Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Feb 19, 2020

Kowa Achieves Goal Of Randomizing 10,000 Patients Into Landmark "PROMINENT" Cardiovascular Outcomes Study Of K-877 (Pemafibrate)

Jan 02, 2020

Global Call To Action on Familial Hypercholesterolemia Aims to Improve Diagnosis and Treatment Worldwide

Sep 30, 2019

Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag(TM)

May 01, 2019

LAL-D Treatment Market Size Worth $954 Million by 2025 : Grand View Research, Inc.

Dec 11, 2018

Statin Markets: Worldwide Analysis & Outlook, 2019-2023 - Rising Prevalence of Hypercholesterolemia

Sep 13, 2018

Hyperlipidemia Drugs Market Worth $22.6 Billion by 2022 | CAGR: 2.3%: Grand View Research, Inc.

May 01, 2018

Medicure announces availability of ZYPITAMAG(TM) (pitavastatin) in the U.S.

Mar 19, 2018

Lipid Disorder Treatment Market is Estimated to Reach Over US$ 40 Bn by 2026: Transparency Market Research

Mar 07, 2018

Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.

Nov 13, 2017

Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments

Oct 03, 2017

TV Icon and Heart Disease Survivor Regis Philbin Joins Kowa Pharmaceuticals America, Inc. to Launch National Education Campaign "Take Cholesterol to Heart"